| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 30,000 | $17.37 | $521,137.14 | -2.2% | -19.3% | -58.9% | |
| Jul 15, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 11,413 | $3.23 | $36,900.95 | -0.5% | -3.5% | -44.3% | |
| Jul 15, 2022 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Sell | 15,800 | $16.14 | $255,005.67 | -0.4% | +41.4% | +52.9% | |
| Jul 15, 2022 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 588 | $14.28 | $8,396.29 | -0.3% | +39.0% | +103.5% | |
| Jul 14, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 2,700 | $1.04 | $2,802.00 | +5.1% | +10.2% | -15.1% | |
| Jul 14, 2022 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Chairman &CEO | Sell | 19,875 | $95.88 | $1,905,625.73 | -3.7% | -14.7% | -3.6% | |
| Jul 14, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | 10% Owner, See Remarks | Buy | 326,062 | $9.32 | $3,038,315.28 | +0.9% | +2.1% | +25.0% | |
| Jul 13, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $8.02 | $120,350.00 | +0.1% | +1.1% | +24.2% | |
| Jul 12, 2022 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 254 | $15.79 | $4,010.66 | -0.6% | +35.4% | +47.6% | |
| Jul 12, 2022 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 2,725 | $1.84 | $5,014.00 | -5.0% | -6.0% | +79.7% | |
| Jul 12, 2022 | BLFS Biolife Solutions Inc | De Greef Roderick74 | COO &President | Sell | 9,158 | $15.79 | $144,604.82 | -6.9% | +35.4% | +47.6% | |
| Jul 12, 2022 | RSCF Reflect Scientific, Inc. | Boyce Kim | CEO, CFO | Buy | 50,000 | $0.10 | $5,000.00 | +0.1% | - | - | |
| Jul 11, 2022 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 1,500 | $32.98 | $49,470.00 | -79.8% | +22.2% | +163.3% | |
| Jul 8, 2022 | EW Edwards Lifesciences Corp | Wang Huimin68 | Cvp, Japan &Intercontinental | Sell | 3,675 | $97.60 | $358,680.00 | -3.6% | -12.1% | -8.3% | |
| Jul 8, 2022 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 6,725 | $97.60 | $656,360.00 | -9.7% | -12.1% | -8.3% | |
| Jul 8, 2022 | STIM Neuronetics, Inc. | MacAn William Andrew66 | Sr. VP, GC, CCO And Secretary | Sell | 2,746 | $3.60 | $9,885.60 | -0.8% | -13.6% | -42.7% | |
| Jul 8, 2022 | ECIA Encision Inc | Geary Peter D | Dir Of Strategic Integration | Buy | 40,000 | $0.41 | $16,400.00 | New | - | - | |
| Jul 8, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 1,453 | $22.07 | $32,063.18 | -0.1% | -22.9% | -67.0% | |
| Jul 8, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $7.96 | $119,450.00 | +0.1% | +11.3% | +25.8% | |
| Jul 7, 2022 | IRTC Irhythm Holdings, Inc. | Devine Douglas57 | Chief Operating Officer &CFO | Sell | 10,109 | $114.22 | $1,154,649.98 | -25.4% | +18.9% | -12.6% | |
| Jul 7, 2022 | INCY Incyte Corp | Iyengar Vijay K62 | EVP, Gmapps | Sell | 5,787 | $79.38 | $459,372.06 | -12.6% | -14.0% | -23.2% | |
| Jul 7, 2022 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $11.19 | $223,800.00 | -0.3% | +36.0% | -24.7% | |
| Jul 7, 2022 | INCY Incyte Corp | Flannelly Barry P50 | EVP &General Manager Us | Sell | 2,873 | $79.38 | $228,058.74 | -3.8% | -14.0% | -23.2% | |
| Jul 6, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 2,291 | $3.07 | $7,033.37 | -0.7% | +25.2% | -36.9% | |
| Jul 6, 2022 | MASS 908 Devices Inc. | Brown Christopher D.85 | Chief Technology Officer | Sell | 10,000 | $21.28 | $212,768.00 | -0.5% | -13.7% | -67.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.